Organ-On-Chips market by Models (Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip and more), By Applications, By Trends and 2021 Market Forecast

Starting Price : $ 4000.00 $ 2680.00 | Pages : 105 | Published : July 2018 | SKU CODE : o&s017 | Format :

Request Sample

Organ-On-Chips Market Definition

Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate key physiological functions of body organs. These cells are placed in an environment which artificially replicates aspects of human body such as morphology, movement, flow, electrical stimuli and liquid gradients.

Organ-On-Chips Market Size

The global organ-on-chips market reached a value of nearly $34 million in 2017, having grown at a compound annual growth rate (CAGR) of more than 55% since 2013.

The small size of the market is mainly because OOCs have not yet been fully commercialized. They are still in the research and development phase and are being used by a limited number of end-users.

Going forward, it is expected to rise at this high CAGR due to an increase in the number of collaborative sales agreements between the pharmaceutical companies and university spin-offs and the entry of new advanced models of OOCs into the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this market in future.

Grants by government and non-government entities have been the key drivers for the global OOC industry to date. The ability of OOC models to cut drug development costs drastically will be a key market driver in the future.

Organ-On-Chips Market Drivers

The Key drivers of the organ-on-chips market include:

Improved Drug Screening With Organs-On-Chips Will Drive Demand - 2D cell cultures, 3D cell cultures and OOCs are in-vitro techniques as the techniques are carried out in laboratories, whereas experiment on animals is an in-vivo technique. 2D culture systems are considered to have the lowest drug predictability as they fail to provide a suitable platform for the cells to obtain the required results. 3D cell cultures such as 3D organoids and bioreactors have better drug predictability than 2D. Animal models have the advantage of providing an in-vivo environment to the drug, but they have limitations as some drugs which may exhibit the best results in animal models may fail to demonstrate the same on humans.

The standard protocol for new drug testing involves 2D cell culture based tests, followed by animal model tests and clinical trials. Most drugs fail during clinical trials and only about 10% compounds progress after trails. This failure can be attributed to both the in-vivo 2D cell culture tests and the in-vitro animal models. It therefore becomes imperative to establish cell based systems that can more realistically mimic the in-vivo cell behaviors and provide more predictable results. Organ-on-chip is a newer human cell-based approach which enables scientists to predict more accurately how effective a therapeutic candidate would be in clinical studies. The improved predictability provided by organ-on-chip is considered a key market driver.

Organ-On-Chips Market Restraints

The key restraints on the organ-on-chips market include:

Regulatory Hurdles For Drug Approvals - Stringent drug regulatory processes are a major restraint for the widespread use of OOCs by pharmaceutical companies. Drug regulatory authorities scrutinize the preclinical and clinical investigational data of a drug molecule to validate and approve it. The data generated by testing the drug in animal models and humans are required for the drug approval process.

At present the regulatory authorities do not consider the data obtained by testing the drugs on OOCs sufficient proof for approval. Data predicting the efficacy of a drug molecule obtained by the chips can be submitted but only along with the trial data from animal and human subjects for the approval process. These drug regulations limit the use of OCCs by end-users.

Organ-On-Chips Market Trends

Major trends influencing the organ-on-chips market include:

Developments In The Testing Of Human Organs-On-Chips - Human organs-on-chips (OOCs) are miniaturized versions of lungs, livers, kidneys, heart, brain, intestines and other vital human organs embedded in a chip. With advances in OOC technology, drug regulatory bodies have started testing OOCs for their reliability and their use as an alternative to animal testing.   For instance, in April 2017, the US FDA announced an agreement with Emulate Inc., a US-based biotechnology company, to evaluate the company’s human organ-on-chip technology in laboratories. The OOC technology offers a less time-consuming and cost-effective way to test drugs, foods, cosmetics and dietary supplements for efficacy and toxicity. Emulate Inc. was founded by researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University, and is the first commercial organ-on-chip venture. Companies such as Johnson & Johnson and Merck have also partnered with Emulate to test and develop applications for its human OOC technology.

Organ-On-Chip Technology In Space - Organ-on-chip technology is evolving and is finding its way into space research. For example, five grants have been awarded by the US Center for the Advancement of Science in Space (CASIS) and the National Center for Advancing Translational Science (NCATS) to research focused on human physiology and disease onboard the International Space Station (ISS) U.S. National Laboratory. Data from this research is expected to help scientists develop and advance novel technologies to improve human health. NCATS will provide initial funding of about $6 million to use tissue chip technology for this research.  Again, the University of Washington School of Pharmacy and UW Medicine researchers, in collaboration with Novartis, a Seattle-based OOC company, are developing a “kidney-on-a-chip” model to be used in space for drug, toxin and environmental exposures, and to understand how microgravity and other factors affect kidney health. This project is funded by NCATS with $3 million grant, and CASIS will contribute the space flight, time in station, and space station crew costs, for an in-kind total of $8 million.

Recommendations In The Organ-On-Chips Market

Recommendations – To take advantage of the opportunities, The Business Research Company recommends the organ-on-chips companies to focus on integrated approach, OOCs for human disease models, personalized drug tests and regulatory status of tests using OOCs.

Organ-On-Chips Market Segmentation

The Organ-On-Chips market is segmented by organ type, by end user industry and by geography.
By Organ Type - The organ-on-chips market is segmented by service type into
    • a) Lung-on-chip
    • b) Heart-on-chip
    • c) Liver-on-chip
    • d) Intestine-on-chip
    • e) Kidney-on-chip
    • f) Skin-on-chip
    • g) Blood-Brain-Barrier-On-Chip
    • h) Other Organ Models
Lung-on-chip constituted 20% of the global OOC market in 2017. More than 50% of the global OOC market is currently contributed by organ models for lung, kidney, intestine, heart and liver.
By End Users - The organ-on-chips market is segmented by end users into
    • a) Pharmaceuticals
    • b) Research Organizations
    • c) Consumer Goods and Cosmetics
    • d) Food and Beverages
    • e) Others
By Geography - The organ-on-chips market is segmented into
    • o North America
    • o Europe
    • o Asia
    • o Rest Of World (ROW)
North America is the largest market for organ-on-chips, accounting for almost 60% of the global market. It was followed by Europe, Asia and then the other regions. Going forward, Europe and Asia will be the fastest growing regions in this market.

Organ-On-Chips Competitive Landscape

Major Competitors are:
    • • CN Bio Innovations
    • • Emulate
    • • TissUse GmbH
    • • Mimetas
    • • HµREL Corporation
    • • Nortis
    • • InSphero AG
    • • Tara Biosystems
    • • AxoSim Technologies
    • • Organovo Inc.
    • • Ascendance Biotechnology
    • • HemoShear

  1. 1. Executive Summary
  2. 2. Preface
  3. 3. Global Organ-On-Chip Market – Introduction
  4. 4. Organ-On-Chip Market Characteristics
    • 4.1.1 Organs-On-Chips Origin And Significance
    • 4.1.2 Organ-On-Chip Features
  5. 4.2 Organ-On-Chip Market – Product Analysis
    • 4.2.1 Technical Description
    • 4.2.2 Typical Organ-On-Chip Structure
    • 4.2.3 Product Design Materials
    • 4.2.4 Product Design Methodologies
  6. 5. Overview Of Organ-Specific Models
    • 5.1 Lung-On-Chip
    • 5.2 Heart-On-Chip
    • 5.3 Liver-On-Chip
    • 5.4 Intestine-On-Chip
    • 5.5 Kidney-On-Chip
    • 5.6 Skin-On-Chip
    • 5.7 Blood-Brain-Barrier-On-Chip
    • 5.8 Human-On-Chip
  7. 6. Organ-On-Chip Applications
  8. 7. Organ-On-Chip Commercialization
  9. 8. Organ-On-Chip Market Penetration
  10. 9. Price Information
  11. 10. Organ-On-Chip Market Trends and Models
    • 10.1 Global Organ-On-Chip Market – Business Model
    • 10.2 Five Forces Analysis
    • 10.3 Market Trends
      • 10.3.1 Developments In The Testing Of Human Organs-On-Chips
      • 10.3.2 Organ-On-Chip Technology In Space
      • 10.3.3 Automated Monitoring Of Organs-On-Chips
      • 10.3.4 3D Printing Of Organs-On Chips
      • 10.3.5 Manufacturers Tying Up With End-Users To Design Tailor-made Products
      • 10.3.6 Investment In Integration Of Individual Organs-on-Chips Into Humans-on-Chips
      • 10.3.7 Strong Focus On Development of Custom Organs-On-Chips
      • 10.3.8 Manufacturers Work On Disease Models To Expedite Drug Testing
  12. 11. Global Organ-On-Chip Market – Market Size Analysis
    • 11.1 Market Sizing Methodology
    • 11.2 Global Market For Organs-on-Chips
      • 11.2.1 Global Market For Organs-On-Chips (Historic 2013-2017)
      • 11.2.2 Global Market For Organs-On-Chips (Forecast 2017-2021)
    • 11.3 Global Organ-On-Chip Market Segmentation By Organ Type
    • 11.4 Global Organ-On-Chip Market Segmentation By End-Users
      • 11.4.1 Pharmaceuticals
      • 11.4.2 Research Organizations
      • 11.4.3 Consumer Goods and Cosmetics
      • 11.4.4 Food and Beverages
      • 11.4.5 Others
    • 11.5 Global Organ-On-Chip Market Segmentation By Geography
      • 11.5.1 North America
      • 11.5.2 Europe
      • 11.5.3 Asia
      • 11.5.4 Rest Of World (ROW)
  13. 12. Global Organ-On-Chip Market – Drivers And Restraints
    • 12.1 Drivers
      • 12.1.1 Improved Drug Screening With Organs-On-Chips Will Drive Demand
      • 12.1.2 Drug Testing Cost Savings to Drive Demand For OOCs
      • 12.1.3 Government Funding Drives The Market For Organs-On-Chips
      • 12.1.4 Ethical Concerns With Respect To Animal Models Will Drive The Organ-On-Chip Market
    • 12.2 Restraints
      • 12.2.1 Complex Manufacturing Techniques Are A Restraint On Organ-On-Chip Market Growth
      • 12.2.2 Requirement For Specialized Equipment Will Be A Challenge For The Organ-On-Chip Market
      • 12.2.3 Regulatory Hurdles For Drug Approvals
  14. 13. Global Organ-On-Chip Market – Funding Landscape
    • 13.1.1 Funding Landscape – North America
    • 13.1.2 Funding Landscape – Europe
    • 13.1.3 Funding Landscape – Asia
    • 13.1.4 Funding Landscape – ROW
  15. 14. Global Organ-On-Chip Market – Competitive Landscape
    • 14.1 Key Players In The OOC Market
    • 14.2 CN Bio Innovations
    • 14.3 Emulate
    • 14.4 TissUse
    • 14.5 Mimetas
    • 14.6 Hµrel
    • 14.7 Nortis
    • 14.8 Insphero
    • 14.9 Tara Biosystems
    • 14.10 AxoSim Technologies LLC
    • 14.11 Organovo
    • 14.12 Ascendance
    • 14.13 HemoShear
  16. 15. Global Organ-On-Chip Market – Conclusions and Strategies
    • 15.1 Conclusions
    • 15.2 Strategies
  17. 16 Appendix
    • 16.1 Interview Summaries
      • 16.1.1 Interview Number 1
      • 16.1.2 Interview Number 2
      • 16.1.3 Interview Number 3
      • 16.1.4 Interview Number 4
      • 16.1.5 Interview Number 5
      • 16.1.6 Interview Number 6
      • 16.1.7 Interview Number 7
    • 16.2 Abbreviations
    • 16.3 Research Methodology
    • 16.4 Currencies
    • 16.5 Research Inquiries
    • 16.6 The Business Research Company
Dental Tourism And Adoption Of New Technology In The Dental Services Industry
Global Contract Research Organizations market | Characteristics, Forecast Size, Trends
Global Veterinary Services market | Characteristics, Forecast Size, Trends
Teletherapy: A Solution To Diagnose And Treat Patients Online
DocOn: An App For Accessing Prescription Records Online
Micro Birthing To Simulate The Infants Immune System
Mathematical Modelling For The Treatment Of Brain Diseases
Medical And Diagnostic Laboratory Services Global Market Report 2019
View Report
Physicians And Other Health Practitioners Global Market Report 2019
View Report
Ambulance Services Global Market Report 2019
View Report
Residential Substance Abuse And Mental Health Facilities Market Global Briefing 2018
View Report
Home Health Care Providers Global Market Report 2018
View Report
Diagnostic Imaging Centers Global Market Report 2018
View Report
Home Health Care And Residential Nursing Care Services Global Market Report 2018
View Report
Retirement Communities Global Market Report 2018
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)